A Weakly Supervised Deep Learning Method for Guiding Ovarian Cancer Treatment and Identifying an Effective Biomarker

Quantitative analysis of abnormalities in gynecologic cytopathology with deep learning

(2021) Jing Ke et al.   LABORATORY INVESTIGATION

Data-efficient and weakly supervised computational pathology on whole-slide images

(2021) Ming Y. Lu et al.   Nature Biomedical Engineering

Multi-Modal Evolutionary Deep Learning Model for Ovarian Cancer Diagnosis

(2021) Rania M. Ghoniem et al.   Symmetry-Basel

Weakly Supervised Deep Learning Approach to Breast MRI Assessment

(2021) Michael Z Liu et al.   ACADEMIC RADIOLOGY

Artificial intelligence-assisted fast screening cervical high grade squamous intraepithelial lesion and squamous cell carcinoma diagnosis and treatment planning

(2021) Ching-Wei Wang et al.   Scientific Reports

Deep Learning Fast Screening Approach on Cytological Whole Slides for Thyroid Cancer Diagnosis

(2021) Yi-Jia Lin et al.   Cancers

Weakly-supervised deep learning for ultrasound diagnosis of breast cancer

(2021) Jaeil Kim et al.   Scientific Reports

AIM2 Inflammasome in Tumor Cells as a Biomarker for Predicting the Treatment Response to Antiangiogenic Therapy in Epithelial Ovarian Cancer Patients

(2021) Po-Chao Hsu et al.   Journal of Clinical Medicine

The Potential Role of Complement System in the Progression of Ovarian Clear Cell Carcinoma Inferred from the Gene Ontology-Based Immunofunctionome Analysis

(2020) Kuo-Min Su et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook

(2020) Josep Garcia et al.   CANCER TREATMENT REVIEWS

Treatment of Recurrent Epithelial Ovarian Cancer

(2020) Carlota Claussen et al.   GEBURTSHILFE UND FRAUENHEILKUNDE

Deep Learning Methods for Lung Cancer Segmentation in Whole-Slide Histopathology Images—The ACDC@LungHP Challenge 2019

(2020) Zhang Li et al.   IEEE Journal of Biomedical and Health Informatics

Applications of machine learning in drug discovery and development

(2019) Jessica Vamathevan et al.   NATURE REVIEWS DRUG DISCOVERY

Clinical-grade computational pathology using weakly supervised deep learning on whole slide images

(2019) Gabriele Campanella et al.   NATURE MEDICINE

Inflammasome as a promising therapeutic target for cancer

(2019) Chaelin Lee et al.   LIFE SCIENCES

Artificial intelligence in digital pathology — new tools for diagnosis and precision oncology

(2019) Kaustav Bera et al.   Nature Reviews Clinical Oncology

Cascade R-CNN: High Quality Object Detection and Instance Segmentation

(2019) Zhaowei Cai et al.   IEEE TRANSACTIONS ON PATTERN ANALYSIS AND MACHINE INTELLIGENCE

Automatic classification of ovarian cancer types from cytological images using deep convolutional neural networks

(2018) Miao Wu et al.   BIOSCIENCE REPORTS

Ovarian cancer statistics, 2018

(2018) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning

(2018) Nicolas Coudray et al.   NATURE MEDICINE

Survival outcome prediction in cervical cancer: Cox models versus deep-learning model

(2018) Koji Matsuo et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Deep learning provides a new computed tomography-based prognostic biomarker for recurrence prediction in high-grade serous ovarian cancer

(2018) Shuo Wang et al.   RADIOTHERAPY AND ONCOLOGY

Faster R-CNN: Towards Real-Time Object Detection with Region Proposal Networks

(2017) Shaoqing Ren et al.   IEEE TRANSACTIONS ON PATTERN ANALYSIS AND MACHINE INTELLIGENCE

Integrating the dysregulated inflammasome-based molecular functionome in the malignant transformation of endometriosis-associated ovarian carcinoma

(2017) Chia-Ming Chang et al.   Oncotarget

Normalization of Tumor Vessels by Tie2 Activation and Ang2 Inhibition Enhances Drug Delivery and Produces a Favorable Tumor Microenvironment

(2016) Jin-Sung Park et al.   CANCER CELL

Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma

(2016) Marta Szajnik et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Immune checkpoint inhibition in ovarian cancer

(2016) Junzo Hamanishi et al.   INTERNATIONAL IMMUNOLOGY

Antiangiogenic therapy in oncology: current status and future directions

(2016) Gordon C Jayson et al.   LANCET

AIM2 inflammasome in infection, cancer, and autoimmunity: Role in DNA sensing, inflammation, and innate immunity

(2015) Si Ming Man et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial

(2015) Amit M Oza et al.   LANCET ONCOLOGY

Deep learning

(2015) Yann LeCun et al.   NATURE

The Combination of Circulating Ang1 and Tie2 Levels Predicts Progression-Free Survival Advantage in Bevacizumab-Treated Patients with Ovarian Cancer

(2014) A. Backen et al.   CLINICAL CANCER RESEARCH

Prognostic importance of cell-free DNA in chemotherapy resistant ovarian cancer treated with bevacizumab

(2014) Karina Dahl Steffensen et al.   EUROPEAN JOURNAL OF CANCER

Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2013) J. A. Ledermann et al.   ANNALS OF ONCOLOGY

Markers of Response for the Antiangiogenic Agent Bevacizumab

(2013) Diether Lambrechts et al.   JOURNAL OF CLINICAL ONCOLOGY

Inflammation and oxidative stress in angiogenesis and vascular disease

(2013) Young-Woong Kim et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

AIM2, an IFN-Inducible Cytosolic DNA Sensor, in the Development of Benign Prostate Hyperplasia and Prostate Cancer

(2013) Larissa Ponomareva et al.   MOLECULAR CANCER RESEARCH

EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesis

(2012) Francesco Crea et al.   CANCER AND METASTASIS REVIEWS

Antiangiogenic agents as a maintenance strategy for advanced epithelial ovarian cancer

(2012) Bradley J. Monk et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases

(2011) Peter Carmeliet et al.   NATURE REVIEWS DRUG DISCOVERY

Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer

(2011) Robert A. Burger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Systematic Analysis of Breast Cancer Morphology Uncovers Stromal Features Associated with Survival

(2011) A. H. Beck et al.   Science Translational Medicine

The Inflammasomes

(2010) Kate Schroder et al.   CELL

Serous papillary peritoneal carcinoma: Unknown primary tumour, ovarian cancer counterpart or a distinct entity? A systematic review

(2009) George Pentheroudakis et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY